Recent quotes:

Treatment Benefits of the remedē® System Sustained Through 36 Months in Patients with Central Sleep Apnea | Respicardia

The latest results build upon prior published data in The Lancet and the American Journal of Cardiology which demonstrated that the remedē System significantly reduces the severity of CSA and improves sleep, quality of life and patient satisfaction,3 and the benefits are sustained.4